Choose another ingredient

THE INGREDIENT LIBRARY · Entry 596

Cocoa flavanol extract

Cocoa flavanol extract
Decorative illustration of Cocoa flavanol extract. Source material and generic packaging are illustrative, not an identification reference or evidence of product equivalence.

At a glance

Cocoa flavanol extract was tested in the large COSMOS trial. The primary total cardiovascular-event result was not significant, despite a favorable secondary cardiovascular-death finding.

Key cautions

  • Do not replace heart medicines or eat extra sweets to imitate the trial.
Read the full cautions

What’s inside

The trial supplement supplied a measured flavanol mixture including (-)-epicatechin. The extract is not pure epicatechin or an interchangeable chocolate serving.

Uses in brief

  • Negative evidence: Cocoa extract has not clearly reduced total cardiovascular events.

History, folklore and reported uses

History, folklore and traditional uses

COSMOS studied a modern capsule from 2015 through 2020. This formulation’s research history should be kept separate from the much older food history of cacao.

Traditional, historical and reported uses

  1. Cardiovascular prevention research
    Human researchWhy this label?

    Reported use or research history, with the form and evidentiary limits stated in the entry. This label is not a treatment endorsement.

    COSMOS followed 21,442 older adults for a median 3.6 years. The primary event outcome was not significantly reduced; the secondary death signal needs careful interpretation.

Only documented uses and research history are included. Modern study products do not inherit ancient clinical evidence.

Story sources

Health topics: evidence and cautions

These notes describe a specific research context and preparation. A topic link is not a treatment recommendation.

Cardiovascular health · No benefit or possible harm

Form and route: Standardized oral cocoa extract studied in COSMOS · oral

Cocoa extract has not clearly reduced total cardiovascular events.

Evidence: large_randomized_trial_mixed

COSMOS enrolled 21,442 older adults. Its primary cardiovascular endpoint was not significantly lower; a secondary cardiovascular-death finding favored extract.

Limits

Secondary and adherence-based findings do not override the primary result. Chocolate bars were not tested.

Cautions

  • Do not replace heart medicines or eat extra sweets to imitate the trial.

Read the full Cardiovascular health topic record

Identity & detailed reference

Identity

An oral cocoa-derived extract characterized for flavanols, including epicatechin, as tested in COSMOS. It is separate from cocoa powder and chocolate.

Ingredient details, preparation and research

Source plant or material

Theobroma cacao

Plant family / material: Malvaceae (mallow family)

Forms and route

Standardized oral cocoa extract studied in COSMOS. Oral route only unless a historical context is expressly separated.

Vitamins and minerals

No universal serving values apply to this formulation. A constituent being present does not establish nutritional adequacy or clinical benefit.

Traditional and reported uses

  • Cocoa extract has not clearly reduced total cardiovascular events.

Contraindications and cautions

  • Do not replace heart medicines or eat extra sweets to imitate the trial.
  • No major safety signal in the trial does not establish all products or long-term use in other populations.

Similar items and how they compare

  • Cocoa/chocolate food (existing card 246)

    Same source crop.

    Chocolate sugar, fat and flavanol content do not match a standardized extract.

Identity and composition

An oral cocoa-derived extract characterized for flavanols, including epicatechin, as tested in COSMOS. It is separate from cocoa powder and chocolate. The trial supplement supplied a measured flavanol mixture including (-)-epicatechin. The extract is not pure epicatechin or an interchangeable chocolate serving.

What the human evidence can show

COSMOS enrolled 21,442 older adults. Its primary cardiovascular endpoint was not significantly lower; a secondary cardiovascular-death finding favored extract. Secondary and adherence-based findings do not override the primary result. Chocolate bars were not tested.

Safety and limits

Do not replace heart medicines or eat extra sweets to imitate the trial. No major safety signal in the trial does not establish all products or long-term use in other populations.

Evidence limits

  • Secondary and adherence-based findings do not override the primary result. Chocolate bars were not tested.
  • A product-specific result cannot establish every commercial preparation.

Entry sources